2025: A Year of Milestones in DS-AD
The medical advances made within the Down syndrome community over the past few decades have…
Shannon BergstresserJanuary 31, 2025
RAND report shows benefit of investment in future health outcomes for adults with Down syndrome
10/1/2024 | For immediate release | Contact: Kate O'Neill ([email protected]) Investment in Alzheimer’s Research Today…
Pathways to Parity Program Approved for $250K PCORI Engagement Award
Project will empower advocates, enhance research for people at high risk of Alzheimer’s disease who…
Shannon BergstresserAugust 13, 2024
Updates from AAIC: Down syndrome community boosted by FDA confirmation of label and new anti-amyloid clinical trial
Information revealed at the 2024 AAIC conference on the ACTC-DS-led study in DS-associated Alzheimer's disease…
Kate O’NeillAugust 2, 2024
Down syndrome population will see a clinical trial of new Alzheimer’s drug
Major pharmaceutical company announces Down syndrome population will see a clinical trial of new Alzheimer’s…
Kate O’NeillJune 11, 2024
Clinical Trials Day: A Historic Review of the First Clinical Trial
James Lind, a United Kingdom's Royal Navy surgeon, is considered the “Father of Clinical Trials.”…
Shannon BergstresserMay 17, 2024
Down syndrome collaborators now published in Alzheimer’s and Dementia
“Adapting prescribing criteria for amyloid‐targeted antibodies for adults with Down syndrome” published in the journal…
Kate O’NeillMarch 15, 2024
LuMind IDSC statement on FDA Advisory Committee for promising Alzheimer’s drug, donanemab
LuMind IDSC is encouraged by today’s news that the U.S. Food and Drug Administration (FDA)…
Kate O’NeillMarch 8, 2024
Study: Medicare, Medicaid, and Dual Enrollment for Adults with Intellectual and Developmental Disabilities.
Medicare, Medicaid and Dual Enrollment for Adults with IDD Boston University School of Public Health…
Shannon BergstresserJanuary 31, 2024
Message from the CEO: a look ahead to 2024
“I want to enjoy my life for a long time. I want to grow old…
Kate O’NeillJanuary 18, 2024
